Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation.
Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation.
复制标题
DOI:
10.1016/j.biopsych.2009.04.015
复制
发表时间:
2009-09-01
影响因子:
10.6
通讯作者:
Jope, Richard S.
中科院分区:
文献类型:
--
作者:
Eom, Tae-Yeon;Jope, Richard S.
Adult neurogenesis augments neuronal plasticity, and deficient neurogenesis may contribute to mood disorders and schizophrenia and impede treatment responses. Since these diseases may be associated with inadequately controlled glycogen synthase kinase-3 (GSK3), we tested if blocked inhibitory serine-phosphorylation of GSK3 impairs neurogenesis. Neural precursor cell (NPC) proliferation was measured by dentate gyrus BrdU labeling in GSK3alpha/beta21A/21A/9A/9A knockin mice with serine-to-alanine mutations to block inhibitory serine-phosphorylation of GSK3 while it remains within the physiological range, since GSK3 is not overexpressed. There was a drastic 40% impairment in neurogenesis in vivo in GSK3 knockin mice compared with wild-type mice. Impaired neurogenesis could be due to effects of GSK3 in NPCs or in surrounding cells that modulate NPCs. In vitro proliferation was equivalent for NPCs from GSK3 knockin and wild-type mice, suggesting an in vivo deficiency in GSK3 knockin mice of external support for NPC proliferation. Measurements of two neurotrophins that promote neurogenesis demonstrated less hippocampal vascular endothelial growth factor, but not brain-derived growth factor, in GSK3 knockin mice than wild-type mice, reinforcing the possibility that insufficient environmental support in GSK3 knockin mice may contribute to impaired neurogenesis. In vivo chronic co-administration of lithium and fluoxetine, which each increase inhibitory serine-phosphorylation of wild-type GSK3, increased NPC proliferation in wild-type, but not GSK3 knockin, mice. Blocked inhibitory control of GSK3 impaired neurogenesis and the capacity of therapeutic drugs to stimulate neurogenesis, likely through deficient environmental factors that support neurogenesis, which may contribute to psychiatric diseases and responses to therapeutic drugs.
登录
查看更多内容
影响因子:
4.7
作者:
Chen, G;Rajkowska, G;Manji, HK
通讯作者:
Manji, HK
DOI:
10.1073/pnas.120552597
发表时间:
2000-06-20
影响因子:
11.1
作者:
Eisch, AJ;Barrot, M;Nestler, EJ
通讯作者:
Nestler, EJ
影响因子:
10.6
作者:
Duman, RS;Malberg, J;D'Sa, C
通讯作者:
D'Sa, C
DOI:
10.1073/pnas.182296499
发表时间:
2002-09-03
影响因子:
11.1
作者:
Jin, KL;Zhu, YH;Greenberg, DA
通讯作者:
Greenberg, DA
影响因子:
2.9
作者:
Balu, Darrick T.;Hoshaw, Brian A.;Lucki, Irwin
通讯作者:
Lucki, Irwin